116 Disruptors Mapped in COVID-19 Vaccine Supply Chain Study

A comprehensive qualitative analysis of COVID-19 vaccine supply chains has identified 116 distinct disruptors affecting seven interdependent flows: products, information, funds, knowledge, skilled workers, vaccine recipients, and waste. Rather than treating vaccine distribution as a simple linear pipeline, researchers Lawrence and Tajik conceptualize pandemic supply chains as complex adaptive systems where disruptions in one flow cascade through others, creating compounding delays and inefficiencies. The study reveals that financial flow disruptions proved more consequential than anticipated, particularly during Phase 2 when demand exceeded supply.

Rising jet fuel prices, elevated cold-chain storage costs, tariffs on specialized inputs like bioreactors, and working capital shortfalls among small logistics providers created acute pressure on the system. Information-flow problems ranged from cyberattacks to fragmented digital infrastructure, preventing real-time coordination across allocation, ordering, and logistics systems in the United States and globally. Beyond finished-dose shortages, the research documents how single missing inputs (glass tubing, rubber, silicone) could stall entire manufacturing operations.

Knowledge-flow constraints restricted technology transfer through intellectual property protections and limited licensing arrangements, while labor shortages in biologics manufacturing, cold-chain handling, and nursing capacity were compounded by visa delays and border restrictions. This taxonomy provides a diagnostic framework for future pandemic preparedness, demonstrating that effective supply chain resilience requires testing all seven flows simultaneously, not just maximizing dose production.